India pharma companies develop versions of Wegovy to get in

Indian drugmakers are developing their versions of Novo Nordisk's weight-loss treatment, Wegovy, aiming to capitalize on the growing weight-loss market, expected to reach $100 billion a year by the end of the decade. Companies like Sun Pharma, Cipla, Dr Reddy's, and Lupin are working on Wegovy alternatives as Novo Nordisk struggles to meet global demand.

Related Keywords

Denmark , India , China , Japan , Danish , Sun Pharma , Vishal Manchanda , Umang Vohra , Nitin Agarwal , Eli Lilly , World Obesity Federation Atlas , Reuters , Cipla , Expert Market Research , Novo Nordisk , World Obesity Federation , Expert Market , Lupin , Wegovy India , India Pharma Companies , Weight Loss Treatment , Wegovy , Generic Drugmakers , Novo , Systematix ,